The Guillain-Barré syndrome can cause muscle weakness and paralysis.
Johnson & Johnson's (J&J) vaccines for the novel coronavirus disease (COVID-19) may increase the risk of Guillain-Barre syndrome, warned the United States Food and Drug Administration. Guillain-Barré syndrome is a rare and dangerous neurological condition. The autoimmune disease can cause muscle weakness and paralysis.
About 13 million people or about 8 per cent of the fully vaccinated population in the US got the J&J vaccine. Out of this, 100 suspected cases of Guillain-Barré were identified by the FDA officials. Almost all of them required hospitalisation and one person died.
The cases were reported two weeks after vaccination and mostly in males aged 50 and above. About one person in 100,000 each year develops the condition and most of them eventually recover.
Other COVID-19 vaccines in the US, the Moderna and Pfizer have not shown this side effect. Earlier, the single-shot vaccine was issued a warning due to the increased risk of blood clots in those vaccinated.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.